Table 1 Baseline characteristics of the training and validation sets.

From: Nomogram for predicting the success rate of sedation with intranasal dexmedetomidine in paediatric nonpainful diagnostic procedures: a retrospective study

 

Train

Validation

P overall

N = 8466

N = 3629

Status (success %)

  

0.723

No

534 (6.31%)

222 (6.12%)

 

Yes

7932 (93.7%)

3407 (93.9%)

 

Nap before sedation

  

0.760

Yes

5541 (65.5%)

2364 (65.1%)

 

No

2925 (34.5%)

1265 (34.9%)

 

Gender

  

0.251

Female

3259 (38.5%)

1438 (39.6%)

 

Male

5207 (61.5%)

2191 (60.4%)

 

Weight (kg)

13.9 (3.73)

14.0 (3.77)

0.530

Age (months)

34.8 (16.4)

35.2 (16.7)

0.261

Fever

  

0.187

No

7811 (92.3%)

3374 (93.0%)

 

Yes

655 (7.74%)

255 (7.03%)

 

Respiratory diseases:

  

0.388

No

6646 (78.5%)

2875 (79.2%)

 

Yes

1820 (21.5%)

754 (20.8%)

 

Cardiovascular diseases:

  

1.000

No

7777 (91.9%)

3333 (91.8%)

 

Yes

689 (8.14%)

296 (8.16%)

 

Neurological diseases:

  

0.983

No

6274 (74.1%)

2688 (74.1%)

 

Yes

2192 (25.9%)

941 (25.9%)

 

Sedation time

  

0.331

<30 min

4046 (47.8%)

1770 (48.8%)

 

> 30 min

4420 (52.2%)

1859 (51.2%)

 

ASA

  

0.576

4914 (58.0%)

2107 (58.1%)

 

3544 (41.9%)

1516 (41.8%)

 

8 (0.09%)

6 (0.17%)

 

Sedation history

  

0.260

No

6469 (76.4%)

2808 (77.4%)

 

Yes

1997 (23.6%)

821 (22.6%)

 

Snotty before sedation

  

0.317

No

7998 (94.5%)

3411 (94.0%)

 

Yes

468 (5.53%)

218 (6.01%)

 

Sedation method

  

0.583

Intranasal

1850 (21.9%)

776 (21.4%)

 

Intranasal + oral

6616 (78.1%)

2853 (78.6%)

 

SPO2 before sedation

98.4 (1.33%)

98.4 (1.45%)

0.777

Pulse before sedation (bpm)

120 (19.0)

120 (18.5)

0.169